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UV radiation is among the most prevalent stressors in humans and diurnal rodents,
exerting direct and indirect DNA damage, free-radical production, and interaction
with speciﬁc chromophores that affects numerous biological processes. In addition
to its panoply of effects, UVB (290–320 nm) radiation can speciﬁcally affect various
local neuroendocrine activities by stimulating the expression of corticotropin-
releasing hormone (CRH), urocortin, proopiomelanocortin (POMC), and POMC-
derived peptides. Although very little is known about the interplay between the
central hypothalamic–pituitary–adrenal (HPA) axis and the skin HPA axis analog, in
the current issue Skobowiat and Slominski propose a novel mechanism by which
exposure to UVB activates a local HPA axis in skin, which in turn activates the
central HPA axis, with the requirement of a functional pituitary gland. This is the
ﬁrst evidence of the local HPA axis in skin contributing to the central
neuroendocrine response. This raises intriguing possibilities regarding how local
production of cortisol and other HPA axis molecules in skin inﬂuence overall
systemic levels of cortisol and help regulate local and central HPA axes in the
context of homeostasis, skin injury, and inﬂammatory skin disorders.
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The central hypothalamic–pituitary–
adrenal (HPA) axis participates in the
basal and stress-related homoeostasis in
vertebrates. However, stress caused by
physical, mechanical, and biological
injury induces a complex and multi-
faceted signaling cascade that involves
the endocrine, immune, and nervous
systems ultimately resulting in gluco-
corticoid production, which in turn
exert a powerful anti-inﬂammatory
response, counteracting the effects of
various stressors (Slominski et al., 2013).
Recently, the skin has been found to
have its own HPA axis analog and to
produce cortisol locally (Pastar et al.,
2014; Slominski et al., 2013; Vukelic
et al., 2011), and this may have
signiﬁcant importance owing to its
strategic location, continuous exposure
to environmental stressors, and ability
to detect, integrate, and respond to
numerous biological, physical, and/or
psychological stressors. Recently, it has
been shown that psychological stress
can affect skin response (Lin et al.,
2014), representing an example of
central-to-local HPA axis cross talk.
Skobowiat and Slominski (2015; this
issue) now describe new insights
regarding a local-to-central cross talk,
and highlight a more prominent role of
skin in tuning central neuroendocrine
response than previously understood.
Meet the “players”: molecules that
mediate the HPA axis in the skin and
hypothalamus
The human skin analog of the HPA axis
mimics the central HPA axis. Urocortin
or CRH produced by skin cells associates
with CRH receptor type 1 and induces
the production of POMC-derived adre-
nocorticotropic hormone (ACTH) and
β-endorphin peptides, similar to central
HPA. Urocortin, a member of the struc-
turally related family of corticotropin-
releasing hormone (CRH)-like peptides
(CRH, sauvagine, and urotensin I), is
localized primarily in the frontal/tem-
poral cortex, hypothalamus, and in the
anterior pituitary but is also present in
skin (primarily in epidermal and follicular
keratinocytes, sweat glands, blood vessel
walls, and mononuclear inﬂammatory
cells), as well as in the placenta, uterus,
immune system, stomach, adrenal gland,
testis, and heart. Similar to CRH, urocor-
tin is a potent activator of adenylate
cyclase, stimulating cAMP production
and activating protein kinase A–depen-
dent pathways, and similar to CRH it was
previously shown to be induced by UVB
radiation resulting in the upregulation of
tumor necrosis factor (TNF)-α and con-
comitant downregulation of IL-6 and
IL-10 in keratinocytes.
β-Endorphin, the most abundant endo-
genous opioid, normally localizes to
neurons of the central and peripheral
nervous systems and has a role in
analgesia and addiction. In skin, how-
ever, β-endorphin has been shown to
have multiple roles. It is generated post-
translationally by cleavage of its precur-
sor POMC in response to UV radiation,
and hence it has been implicated in
addiction to UV light (Fell et al., 2014). In
addition, it contributes to acute wound
healing by inducing the expression of
K16 and regulating transforming growth
factor-β signaling (Pastar et al., 2014).
Furthermore, β-endorphin expression
has been shown to be upregulated in
wound margin of chronic wounds where
it is hypothesized to downregulate the
expression of the μ-opiate receptor, thus
affecting keratinocyte migration through
negative feedback (Bigliardi et al., 2003).
Melanocortin receptor 2 (MC2R), a
receptor for ACTH, normally found in
the zona fasciculate of the human adrenal
cortex, has recently been found in the
integument, with its levels modiﬁed
by inﬂammatory skin diseases such as
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alopecia areata (Guo et al., 2010). After
association with MC2R, ACTH induces
cutaneous cortisol production. Therefore,
all these molecules have important roles
in skin biology and homeostasis. Apart
from regulating local homeostasis, it
has been postulated that activation of
cutaneous CRH/urocortin, β-endorphin,
ACTH, MC2R, and glucocorticoids
might also affect central body homeo-
stasis via neural and vascular networks
(Slominski et al., 2013). The immune
system is also involved in the regulation
of the HPA axis, as CRH and POMC
expression stimulates proinﬂammatory
cytokines IL-1, IL-6, and TNF-α, which
assist in response to injury and barrier
maintenance. Moreover, UVB and UVC
(but not UVA) radiation can increase
cortisol production in cultured human
skin or human keratinocytes/melanocytes
by decreasing epidermal glucocorticoid
receptor expression and increasing
the cortisol-activating enzyme HSD11β1
(Slominski et al., 2013; Skobowiat and
Slominski, 2015).
Local-to-systemic HPA cross talk
In the current issue, Skobowiat and
Slominski (2015) provide the ﬁrst
evidence that UVB in a rodent skin
model can initiate a central HPA axis
response, thus regulating body homeo-
stasis. Using a C57BL/6 mouse model,
the investigators found increased
expression of urocortin in the epi-
dermis, adnexal structures, and stratum
paniculosum, as well as an increased
cutaneous concentration of CRH,
POMC, ACTH, β-endorphin, MC2R,
StAR, CYP11A1, 3β-HSD, and cortico-
sterone following 400mJ cm−2 UVB.
They also found increased adrenal
levels of MC2R and CYP11B1, as well
as increased plasma levels of CRH,
urocortin, β-endorphin, and cortico-
sterone after UVB exposure. In these
experiments, a functional pituitary
gland was needed to observe this
response. The necessity of an intact
pituitary gland has been reported
previously for UVB-dependent stimula-
tion of α-melanocyte-stimulating hor-
mone (MSH) plasma levels (in contrast
to the classical HPA axis) and for
increased ocular melanocytes after
exposure to UVB (Hiramoto et al.,
2003). In contrast to Skobowiat and
Slominski (2015), who found that
various skin-derived factors acting at
different entry points can activate the
classical HPA axis, Hiramoto et al.
(2003) demonstrated that UVB irradia-
tion can act at the central level at a site
different from the HPA axis, as in the
eye the ﬁnal product of UVB irradiation
is α-MSH. α-MSH leads to increased
expression of prohormone convertase 2,
whereas after irradiation of the skin,
ACTH acts on adrenal glands to stimu-
late steroidogenesis. These examples
demonstrate that the epithelia may
have tissue-speciﬁc responses, but each
is equipped to contribute to central
neuroendocrine regulation. This new
concept of ﬁne-tuning is that peripheral
tissues may provide important control
modulation of systemic regulators and
the HPA axis. The observation that the
local HPA axis in skin contributes to the
central neuroendocrine response raises
interesting possibilities. For example,
how does cortisol production contribute
to systemic levels of cortisol and thus
regulate both local and central HPA
axes in the context of homeostasis, skin
injury, and inﬂammatory skin disorders
(Figure 1)?
The (spot)-light: UVB-mediated
regulation of neuroendocrine response
UVB exposure has long been linked to
skin aging by stimulating the production
of MMP2/MMP9, subsequent collagen
destruction, and inhibition of pro-
collagen I and III expression (Chung
et al., 2001). It is possible that the
induction of IL-1 and induced cortisol
production from the local HPA axis can
also inhibit collagen synthesis and
contribute to skin aging. However,
long-term effects of local HPA axis
stimulation over the course of various
skin diseases or types of injury are not
yet known.
Broadband and narrowband UVB
therapy can successfully treat various
skin disorders including psoriasis, ato-
pic dermatitis, pruritus, cutaneous
lymphoma, and vitiligo among many
other disorders. Several mood and
sleep-related disorders, such as seaso-
nal/nonseasonal affective disorders and
chronic/situational circadian rhythm
sleep disorders, also respond to UVB
phototherapy (Samson Yashar et al.,
2003). However, long-term (adverse)
effects of these therapies remain to be
determined. Although mechanisms by
which UVB mediates its effects are
complex, it is important to recognize
that they extend beyond local tissue
response and likely work by providing
a systemic response and modifying
homeostasis. Local UVB radiation of
the skin has been shown to inﬂuence
systemic immune reactions and attenu-
ate systemic autoimmunity via the
induction of skin-derived dendritic cells
and regulatory T cells, with associated
changes in cytokine levels (Breuer et al.,
2014). In their mouse model, Skobowiat
and Slominski (2015) used a clinically
relevant dose of UVB (400mJ cm2).
However, given that UVB treatment
dose in patients depends on the skin
type and the body surface area exposed,
the true impact of local-to-systemic
HPA axis in patients remains to be
determined. Importantly, these new
Clinical Implications
● Exposure of mouse skin to UVB induces glucocorticoid production both
locally and systemically.
● Whether UVB-induced cortisol production in human skin affects systemic
cortisol levels and serves as a neuroendocrine regulator of the HPA axis is
not known. If skin does indeed contribute to the systemic levels (free
plasma levels) of circulating cortisol, this would provide a paradigm shift
in which skin might be used as a target organ to ﬁne-tune circulating
cortisol levels.
● Using skin to regulate the central HPA axis may attenuate inﬂammatory
and autoimmune diseases, such as scleroderma, psoriasis, atopic
dermatitis, rheumatoid arthritis, and inﬂammatory bowel disease, among
others, and potentially lower morbidity and mortality.
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ﬁndings raise awareness of potentially
important systemic consequences and
side effects of UVB therapy.
Physiological stress and skin diseases
There is growing evidence that physio-
logical stress increases the production
of cortisol systemically, thus potentially
affecting inﬂammatory skin disorders.
This increase in endogenous cortisol
affects the balance between epidermal
proliferation and differentiation that in
turn may compromise the stratum cor-
neum, alter skin permeability, and lead
to possible disease exacerbation. On
the other hand, inhibition of either
glucocorticoid receptor or CRH recep-
tor (CRH-R) prevents stress-induced
cortisol production and protects skin
from glucocorticoid-mediated effects
(Choi et al., 2006). In human skin,
CRH-R expression depends on cell type
and disease states. For example, Tagen
et al. (2007) reported decreased CRH-R
expression in affected skin from patients
with psoriasis, although serum and
cutaneous CRH levels were higher in
those patients compared with controls.
In addition, a recent study indicated
possible systemic HPA dysfunction in
psoriasis (Brunoni et al., 2014). Other
molecules involved in local gluco-
corticoid regulation have been found
to differ upon skin exposure to UV light
(Tiganescu et al., 2011), suggesting a
rather complex mechanism involved in
the regulation of skin homeostasis.
Furthermore, Lin et al. (2014) reported
that both acute and chronic psycho-
logical stress can affect inﬂammatory
dermatoses, and that stress-induced
elevations in endogenous systemic cor-
tisol levels could reduce, rather than
aggravate, cutaneous inﬂammation in
animal models. Taken together, these
ﬁndings suggest that responses to stress
(physiological, psychological, or caused
by tissue injury) may have unexpected
outcomes owing to the complex inter-
play of multiple molecules that regu-
late cortisol levels both locally and
systemically. Understanding the path-
ways by which the skin can contribute
to central neuroendocrine respon-
ses may provide new therapeutic
approaches.
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Figure 1. Cross talk between the central and cutaneous hypothalamic–pituitary–adrenal (HPA)
axes triggered by various types of stress. UVB stress stimulates local cortisol production (via urocortin/
POMC/Local MC2R pathway), as well as systemic cortisol (via adrenal MC2R and CYP11β1), whereas
psychological stressors stimulate the central HPA axis to produce systemic cortisol, β-endorphin, CRH,
and urocortin. The question mark indicates our lack of understanding about the contribution of each HPA
axis to both local and systemic cortisol levels in the context of skin injury and inﬂammatory skin disorders.
ACTH, adrenocorticotropic hormone; β-end, beta-endorphin; CRH, corticotrophin-releasing hormone;
MC2R, melanocortin receptor 2; POMC, proopiomelanocortin.
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